Methodologies for quantifying the results of intravesical chemotherapy of superficial tumors of the bladder
Tóm tắt
Various evaluation methods exist to report results of installation therapy on superficial urinary bladder cancer. The following three, based on material previously gathered from 30 patients treated with adriamycin instillations, are analysed in this study: (1) The graphic expression method which covers the most necessary details, but demands space and does not permit adequate statistical analysis. (2) Evaluating the terms usually used in oncology, i.e. complete response (CR), partial response (PR), total response (TR), no change and progression. These are suitable for statistical analysis and are of crucial relevance in the study of carcinomain situ TIS. In Ta-1 cancers however, these terms (CR, etc.) are not descriptive of time, and since their results depend completely on the choice of endpoints they do not permit realistic statistical analysis. (3) Determining indices (Ri/m, Ri/c) and recurrence rates (RR, MARR, MTBR) in Ta-1 cancers. These factors take into consideration both the time variable and multicentricity in space and time, making rigorous statistical analysis possible. In our opinion Ri/c states most accurately a patient’s clinical course.
Tài liệu tham khảo
Jauhiainen K, Alfthan O: Die Behandlung von Carcinomain situ der Harnblase mit lokaler Adriamycininstillation.Akt Urol 15, 129 (1984).
Jauhianen K, Alfthan O: Adriamycin instillations at recurrence prophylaxis of the superficial urinary bladder cancer.Ann Chir et Gynaec 73, 206 (1985).
Semple J E: Papillomata of the bladder treated with podophyllin.Br Med J 26, 1235 (1948).
Jones H C, Swinney J: Thiotepa in the treatment of tumors of the bladder.Lancet ii, 615 (1961).
Abbasian A, Wallace D M: Intracavitary chemotherapy of diffuse noninfiltrating papillary carcinoma.J Urol 96, 461 (1966).
Pavone-Macaluso M: Intravesical treatment of superficial (T1) urinary bladder tumours. A review of a 15-years experience, in:Diagnostics and Treatment of Superficial Urinary Bladder Tumours, p. 21. Stockholm, Sweden, Montedison Läkemedel AB (1979).
Mishina T, Oda K, Murata S, Ooe H, Mori Y, Takahashi T: Mitomycin C bladder instillation therapy for bladder tumours.J Urol 114, 217 (1975).
Edsmyr F, Berlin T, Boman J, Duchek M, Esposti P L, Gustafsson H, Wijkström H, Collste L G: Intravesical therapy with adriamycin in patients with superficial bladder tumours.Eur Urol 6, 132 (1980).
Jakse G, Hofstädter F, Marberger H: Topical doxorubin hydrochloride therapy for carcinomain situ of the bladder: a follow-up.J Urol 131, 41 (1983).
Ek A, Hellsten S, Henrikson H, Idwall I, Lindholm C-E, Lindholm K, Mikulowski P, Månsson W: Intravesical adriamycin therapy in carcinomain situ of the urinary bladder.Scan J Nephrourol 18, 131 (1984).
Pavone-Macaluso M: Multicentricity in space and time of urothelial malignancy: practical implications, in: Pavone-Macaluso M (ed):Diagnosis and Treatment of Superficial Bladder Tumors, p. 19. Milano, Farmitalia Carlo Erba S.p.A. (1982).
Schulman C C, Robinson M, Denis L, Smith P, Viggiano G, de Pauw M, Dalesio O, Sylvester R, members of the EORTC Genitourinary Tract Cancer Cooperative Group: Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.Eur Urol 8, 207 (1982).
Jacobi G H, Thüroff J W: Prophylactic intravesical doxorubin instillation after TUR of superficial transmitional cell tumours: 3 years experience, in Oliver R T D, Hendry W F, Bloom H J G (eds):Bladder Cancer. Principles of Combination Therapy, p. 85. London, Butterworths (1980).
Altwein J E, Klotz T, Jacobi G H: Stellenwert der Blasenteilresektion zur Therapie des Blasentumours.Akt Urol 11, 351 (1980).
Green D F, Robinson M R G, Graham R, Newling D, Dalesio O, Smith P H: Does intravesical chemotherapy prevent invasive bladder cancer?J Urol 131:33 (1984).
Huland H, Otto U, Droese M, Klöppel G: Long term mitomycin C instillation after transurethral resection of superficial bladder carcinoma Influence on recurrence progression and survival.J Urol 132, 27 (1984).